Clover Leaf Capital Corp. (NASDAQ:CLOE – Get Rating) saw a significant drop in short interest in the month of June. As of June 30th, there was short interest totalling 2,100 shares, a drop of 46.2% from the June 15th total of 3,900 shares. Based on an average daily trading volume, of 10,900 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the shares of the stock are short sold.
Institutional Investors Weigh In On Clover Leaf Capital
Several hedge funds have recently bought and sold shares of CLOE. OTA Financial Group L.P. raised its position in Clover Leaf Capital by 15.8% during the second quarter. OTA Financial Group L.P. now owns 35,758 shares of the company's stock valued at $362,000 after purchasing an additional 4,866 shares in the last quarter. Saba Capital Management L.P. lifted its position in Clover Leaf Capital by 1.2% in the 1st quarter. Saba Capital Management L.P. now owns 220,751 shares of the company's stock worth $2,223,000 after buying an additional 2,687 shares during the last quarter. Goldman Sachs Group Inc. purchased a new stake in Clover Leaf Capital in the first quarter worth approximately $129,000. Mizuho Securities USA LLC boosted its stake in Clover Leaf Capital by 9.3% in the first quarter. Mizuho Securities USA LLC now owns 892,692 shares of the company's stock worth $8,918,000 after buying an additional 76,216 shares in the last quarter. Finally, Karpus Management Inc. grew its position in Clover Leaf Capital by 45.6% during the fourth quarter. Karpus Management Inc. now owns 334,552 shares of the company's stock valued at $3,342,000 after acquiring an additional 104,700 shares during the last quarter. 74.55% of the stock is currently owned by institutional investors.
Get
Clover Leaf Capital alerts:
Clover Leaf Capital Price Performance
Shares of NASDAQ:CLOE remained flat at $10.15 on Monday. The company's stock had a trading volume of 19 shares, compared to its average volume of 19,475. Clover Leaf Capital has a 1 year low of $9.85 and a 1 year high of $10.65. The firm's 50-day moving average price is $10.12 and its 200-day moving average price is $10.07.
About Clover Leaf Capital
(Get Rating)
Clover Leaf Capital Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, and similar business combination with one or more businesses. It intends to focus on the companies operating in the cannabis industry.
Featured Stories
- Get a free copy of the StockNews.com research report on Clover Leaf Capital (CLOE)
- Monthly Dividend Stocks Can Provide Solid Income
- AMC Entertainment Is On Track For Blockbuster Results
- Does Whirlpool's (NYSE: WHR) Russian Exit Give Investors An Attractive Entry?
- Why Did State Street's Stock Rally Despite Weaker Earnings?
- Abbott Labs Stock Can Be a Recession Hedge for Your Portfolio
Receive News & Ratings for Clover Leaf Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Leaf Capital and related companies with MarketBeat.com's FREE daily email newsletter.
